Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.1000
+0.0130 (14.94%)
Mar 31, 2025, 4:00 PM EST

Enzon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
8127182518
Upgrade
Market Cap Growth
66.86%66.86%-62.07%-27.98%37.89%102.39%
Upgrade
Enterprise Value
494162013
Upgrade
Last Close Price
0.110.160.090.250.340.25
Upgrade
PE Ratio
--70.85---
Upgrade
Forward PE
-1.951.951.951.951.95
Upgrade
PS Ratio
445.57445.57-704.0436.26354.51
Upgrade
PB Ratio
2.710.260.150.400.540.39
Upgrade
P/TBV Ratio
3.853.851.985.375.222.51
Upgrade
P/OCF Ratio
10.3310.335.32---
Upgrade
EV/Sales Ratio
145.11347.23-597.2727.83252.38
Upgrade
Asset Turnover
0.000.00-0.000.020.00
Upgrade
Quick Ratio
27.9327.9327.4327.65118.29116.93
Upgrade
Current Ratio
28.1028.1027.6227.89118.50117.07
Upgrade
Return on Equity (ROE)
1.70%1.70%2.99%-0.40%-0.99%-4.87%
Upgrade
Return on Assets (ROA)
-1.75%-1.75%-1.37%-1.35%-0.61%-2.98%
Upgrade
Return on Capital (ROIC)
-1.81%-1.81%-1.42%-1.38%-0.62%-3.03%
Upgrade
Earnings Yield
-6.10%6.72%19.78%-1.02%-1.85%-7.11%
Upgrade
Payout Ratio
163.88%163.88%92.86%---
Upgrade
Buyback Yield / Dilution
----45.23%-15.57%
Upgrade
Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.